Clement Bernard

Dr. Clement Bernard


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Journal of Medical Mycology
Verified
Journal Article
Closed access
CBClement Bernard
Clement Bernard
MGM. Girardot
M. Girardot
CIC. Imbert
C. Imbert

22 August 2018 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
PDF file
CBClement Bernard
Clement Bernard
NRNoémie Renaudeau
Noémie Renaudeau
MMMarie-Laure Mollichella
Marie-Laure Mollichella
NQNathalie Quellard
Nathalie Quellard
MGMarion Girardot
Marion Girardot
CIChristine Imbert
Christine Imbert

16 March 2019 in Biofouling
Verified
Journal Article
Closed access
CBClement Bernard
Clement Bernard
VLVirginie Lemoine
Virginie Lemoine
MHMichel A. Hoogenkamp
Michel A. Hoogenkamp
MGMarion Girardot
Marion Girardot
BKBastiaan P. Krom
Bastiaan P. Krom
CIChristine Imbert
Christine Imbert
Candida albicans and Cutibacterium acnes are opportunistic pathogens that co-colonize the human body. They are involved in biofilm-related infections of implanted medical devices. The objective of this study was to evaluate the ability of these species to interact and form polymicrobial biofilms. SEM imaging and adhesion assays showed that C. acnes adhesion to C. albicans did not have a preference for a specific morphological state of C. albicans; bacteria adhered to both hyphal and yeast forms of C. albicans. C. albicans did not influence growth of C. acnes under anaerobic growth conditions, however under aerobic growth condition, C. albicans enhanced early C. acnes biofilm formation. This favorable impact of C. albicans was not mediated by secreted compounds accumulating in the medium, but required the presence of metabolically active C. albicans. The ability of these microorganisms to interact together could modulate the physiopathology of infections.

26 May 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
VLVirginie Lemoine
Virginie Lemoine
CBClement Bernard
Clement Bernard
CLCharlotte Leman-Loubière
Charlotte Leman-Loubière
BCBarbara Clément-Larosière
Barbara Clément-Larosière
MGMarion Girardot
Marion Girardot
CIChristine Imbert
Christine Imbert
Biofilm-related infections are a matter of concern especially because of the poor susceptibility of microorganisms to conventional antimicrobial agents. Innovative approaches are needed. The antibiofilm activity of extracts of cyanobacteria Arthrospira platensis, rich in free fatty acids, as well as of extract-loaded copper alginate-based nanocarriers, were studied on single- and dual-species biofilms of Candida albicans and Cutibacterium acnes. Their ability to inhibit the biofilm formation and to eradicate 24 h old biofilms was investigated. Concentrations of each species were evaluated using flow cytometry. Extracts prevented the growth of C. acnes single-species biofilms (inhibition > 75% at 0.2 mg/mL) but failed to inhibit preformed biofilms. Nanovectorised extracts reduced the growth of single-species C. albicans biofilms (inhibition > 43% at 0.2 mg/mL) while free extracts were weakly or not active. Nanovectorised extracts also inhibited preformed C. albicans biofilms by 55% to 77%, whereas the corresponding free extracts were not active. In conclusion, even if the studied nanocarrier systems displayed promising activity, especially against C. albicans, their efficacy against dual-species biofilms was limited. This study highlighted that working in such polymicrobial conditions can give a more objective view of the relevance of antibiofilm strategies by taking into account interspecies interactions that can offer additional protection to microbes.

18 December 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
CBClement Bernard
Clement Bernard
CJCamille Juin
Camille Juin
MVMarine Vitry
Marine Vitry
VLVan Thanh Danh Le
Van Thanh Danh Le
JVJulien Verdon
Julien Verdon
MGMarion Girardot
Marion Girardot
Candida albicans is an opportunistic pathogen involved in many infections, especially linked to implanted medical devices. Its ability to form biofilms complicates the treatment of these infections as few molecules are active against sessile C. albicans. The aim of this study was to evaluate the potential of leaves, three-month-old and one-year-old stems of Rubus idaeus L. against C. albicans biofilm growth. Extractions with a polarity gradient were carried out on hydroacetonic extracts and followed by fractionation steps. The obtained extracts and fractions were tested for their anti-biofilm growth activity against C. albicans using XTT method. Compounds of active subfractions were identified by LC-MS. The hexane extracts from leaves and stems were the most active against the fungus with IC50 at 500 and 250 µg/mL. Their bioguided fractionation led to 4 subfractions with IC50 between 62.5 and 125 µg/mL. Most of the components identified in active subfractions were fatty acids and terpenoïds.